| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 18/12/15 | | 11:55:22 | 18 Dec 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/12/15 | | 07:03:00 | 18 Dec 2015 | | | ViiV Healthcare to acquire BMS R&D HIV assets | GlaxoSmithKline PLC | RNS |
| 16/12/15 | | 13:59:17 | 16 Dec 2015 | | | Positive results from sirukumab phIII programme | GlaxoSmithKline PLC | RNS |
| 10/12/15 | | 16:15:50 | 10 Dec 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/12/15 | | 11:51:58 | 10 Dec 2015 | | | Board Committee changes | GlaxoSmithKline PLC | RNS |
| 02/12/15 | | 16:38:12 | 2 Dec 2015 | | | Nucala European Marketing Authorisation Received | GlaxoSmithKline PLC | RNS |
| 01/12/15 | | 15:21:32 | 1 Dec 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/12/15 | | 13:09:32 | 1 Dec 2015 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 13/11/15 | | 14:14:18 | 13 Nov 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/11/15 | | 15:41:37 | 12 Nov 2015 | | | Blocklisting Interim Review | GlaxoSmithKline PLC | RNS |
| 11/11/15 | | 15:10:22 | 11 Nov 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/11/15 | | 07:00:04 | 5 Nov 2015 | | | GSK's Nucala® receives approval from US FDA | GlaxoSmithKline PLC | RNS |
| 03/11/15 | | 11:56:48 | 3 Nov 2015 | | | ViiV Healthcare announces positive results | GlaxoSmithKline PLC | RNS |
| 03/11/15 | | 11:56:31 | 3 Nov 2015 | | | GSK profiles innovative R&D portfolio to investors | GlaxoSmithKline PLC | RNS |
| 02/11/15 | | 12:45:47 | 2 Nov 2015 | | | Director Declaration | GlaxoSmithKline PLC | RNS |
| 02/11/15 | | 10:31:16 | 2 Nov 2015 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 29/10/15 | | 15:39:58 | 29 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 28/10/15 | | 12:00:02 | 28 Oct 2015 | | | 3rd Quarter Results | GlaxoSmithKline PLC | RNS |
| 27/10/15 | | 10:50:14 | 27 Oct 2015 | | | Results of LABA safety study for Advair Diskus | GlaxoSmithKline PLC | RNS |
| 27/10/15 | | 10:50:12 | 27 Oct 2015 | | | 90% efficacy in shingles vaccine for over 70's | GlaxoSmithKline PLC | RNS |
| 20/10/15 | | 17:57:29 | 20 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/10/15 | | 17:52:36 | 20 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/10/15 | | 14:20:31 | 20 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/10/15 | | 14:14:43 | 20 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/10/15 | | 14:02:41 | 20 Oct 2015 | | | Positive Data for Incruse Ellipta Comparisons | GlaxoSmithKline PLC | RNS |
| 19/10/15 | | 15:38:20 | 19 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 19/10/15 | | 15:36:31 | 19 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 19/10/15 | | 15:34:43 | 19 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/15 | | 14:54:39 | 13 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/10/15 | | 17:52:22 | 12 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/10/15 | | 13:29:37 | 8 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 07/10/15 | | 13:26:29 | 7 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/10/15 | | 11:00:50 | 5 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/10/15 | | 15:35:48 | 2 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/10/15 | | 15:32:52 | 2 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/10/15 | | 13:07:20 | 1 Oct 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/10/15 | | 10:58:47 | 1 Oct 2015 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/09/15 | | 14:40:13 | 30 Sept 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 28/09/15 | | 17:54:35 | 28 Sept 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 24/09/15 | | 15:54:19 | 24 Sept 2015 | | | CHMP opinion for mepolizumab (Nucala) in Europe | GlaxoSmithKline PLC | RNS |
| 24/09/15 | | 09:03:55 | 24 Sept 2015 | | | Intention to file Relvar Ellipta for COPD in Japan | GlaxoSmithKline PLC | RNS |
| 23/09/15 | | 09:30:03 | 23 Sept 2015 | | | ViiV Healthcare Phase lllb/IV STRIIVING data | GlaxoSmithKline PLC | RNS |
| 17/09/15 | | 13:13:06 | 17 Sept 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/09/15 | | 16:52:43 | 14 Sept 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/09/15 | | 14:06:31 | 10 Sept 2015 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/09/15 | | 08:00:07 | 9 Sept 2015 | | | Results from the SUMMIT COPD CV Survival Study | GlaxoSmithKline PLC | RNS |
| 01/09/15 | | 10:47:23 | 1 Sept 2015 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |